Astrazeneca Pharma Financials
NSE: ASTRAZEN | BSE: 506820
₹6,944.00
₹3.50
(0.05%)
As on 04-Sep-2026 15:52IST
Market cap
₹17,327 Cr
Revenue (TTM)
₹2,432 Cr
P/E Ratio
102.2
P/B Ratio
19.2
Div. Yield
0.5 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,432.06
|
2,275.58
|
1,716.29
|
1,295.53
|
1,002.97
|
805.60
|
|
|
|
|
|
|
Total Income
|
2,458.54
|
2,304.07
|
1,756.92
|
1,330.33
|
1,029.07
|
820.36
|
|
|
|
|
|
|
Total Expenditure
|
2,202.20
|
2,013.55
|
1,462.32
|
1,111.08
|
837.85
|
719.42
|
|
|
|
|
|
|
EBITDA
|
229.86
|
262.03
|
253.97
|
184.45
|
165.12
|
86.18
|
|
|
|
|
|
|
Depreciation
|
17.24
|
28.58
|
39.99
|
14.94
|
16.26
|
16.95
|
|
|
|
|
|
|
EBIT
|
212.62
|
233.45
|
213.98
|
169.51
|
148.86
|
69.23
|
|
|
|
|
|
|
Interest
|
5.72
|
4.49
|
1.46
|
1.20
|
0.63
|
0.95
|
|
|
|
|
|
|
Other Income
|
26.48
|
28.49
|
40.63
|
34.80
|
26.10
|
14.76
|
|
|
|
|
|
|
Exceptional Items
|
-5.13
|
-5.25
|
-96.79
|
16.43
|
-40.23
|
--
|
|
|
|
|
|
|
Profit before Tax
|
228.25
|
252.20
|
156.36
|
219.54
|
134.10
|
83.04
|
|
|
|
|
|
|
Provision for Tax
|
58.63
|
64.68
|
40.62
|
58.03
|
34.81
|
21.44
|
|
|
|
|
|
|
Profit after Tax
|
169.62
|
187.52
|
115.74
|
161.51
|
99.29
|
61.60
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
872.79
|
872.79
|
770.35
|
711.92
|
588.69
|
511.39
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
134.50
|
394.49
|
159.13
|
97.83
|
68.99
|
73.63
|
|
|
|
|
|
|
Current Liabilities
|
981.81
|
1,109.50
|
908.15
|
467.15
|
484.40
|
392.30
|
|
|
|
|
|
|
Total Liabilities
|
1,989.10
|
2,414.58
|
1,879.19
|
1,298.15
|
1,162.75
|
993.62
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
42.47
|
509.16
|
290.13
|
234.16
|
206.14
|
212.00
|
|
|
|
|
|
|
Current Assets
|
1,739.93
|
1,859.88
|
1,547.50
|
1,042.74
|
935.94
|
765.32
|
|
|
|
|
|
|
Total Assets
|
1,989.10
|
2,414.58
|
1,879.19
|
1,298.15
|
1,162.75
|
993.62
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
758.12
|
750.38
|
639.35
|
575.59
|
451.54
|
373.02
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
121.23
|
98.41
|
137.64
|
131.62
|
122.74
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-15.14
|
65.36
|
27.87
|
58.29
|
100.80
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
18.69
|
30.80
|
21.74
|
18.11
|
4.74
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-91.97
|
-65.59
|
-44.38
|
-24.48
|
-9.46
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-88.42
|
30.57
|
5.23
|
51.92
|
96.08
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
69.41
|
75.01
|
46.30
|
64.60
|
39.72
|
24.64
|
|
|
|
|
|
|
Cash EPS (₹)
|
67.85
|
86.44
|
62.29
|
70.58
|
46.22
|
31.42
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
361.68
|
346.51
|
305.28
|
283.45
|
234.45
|
203.78
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.52
|
36.00
|
32.00
|
24.00
|
16.00
|
10.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
-6.06
|
26.14
|
11.15
|
23.32
|
40.32
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
-1.96
|
20.30
|
15.01
|
30.74
|
40.73
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
31.24
|
21.29
|
33.94
|
24.49
|
17.36
|
|
|
|
|
|
|
ROE (%)
|
20.76
|
23.02
|
15.73
|
24.95
|
18.13
|
12.78
|
|
|
|
|
|
|
ROA (%)
|
9.67
|
8.90
|
7.43
|
13.35
|
9.37
|
6.65
|
|
|
|
|
|
|
EBIT Margin (%)
|
8.74
|
10.26
|
12.47
|
13.08
|
14.84
|
8.59
|
|
|
|
|
|
|
Net Margin (%)
|
6.90
|
8.14
|
6.59
|
12.14
|
9.65
|
7.51
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
9.47
|
9.04
|
13.55
|
11.47
|
9.70
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
31.10
|
32.59
|
32.48
|
29.17
|
24.50
|
-0.98
|
|
|
|
|
|
|
EBIT Growth (%)
|
-12.99
|
9.10
|
26.23
|
13.87
|
115.02
|
-39.98
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-18.33
|
62.02
|
-28.34
|
62.66
|
61.19
|
-33.98
|
|
|
|
|
|
|
EPS Growth (%)
|
-7.49
|
62.02
|
-28.34
|
62.66
|
61.19
|
-33.98
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
13.51
|
7.70
|
20.90
|
15.05
|
12.07
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
102.15
|
103.45
|
185.90
|
82.35
|
81.76
|
103.71
|
|
|
|
|
|
|
Price / Book Value
|
19.16
|
22.39
|
28.19
|
18.77
|
13.85
|
12.54
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.52
|
0.46
|
0.37
|
0.45
|
0.49
|
0.39
|
|
|
|
|
|
|
EV/EBITDA
|
65.84
|
65.23
|
71.21
|
58.36
|
39.84
|
58.85
|
|
|
|
|
|
|
Close Price (₹)
|
8,226.50
|
7,765.50
|
8,607.65
|
5,328.45
|
3,252.80
|
2,551.85
|
|
|
|
|
|
|
High Price (₹)
|
9,850.00
|
10,691.00
|
9,059.05
|
7,220.95
|
3,620.00
|
4,580.00
|
|
|
|
|
|
|
Low Price (₹)
|
7,551.50
|
6,501.60
|
4,800.15
|
3,098.00
|
2,437.75
|
2,525.95
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
17,327.00
|
19,398.64
|
21,515.93
|
13,300.95
|
8,118.24
|
6,388.65
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
1.77
|
1.68
|
1.70
|
2.23
|
1.93
|
1.95
|
|
|
|
|
|
|
Quick Ratio
|
0.73
|
0.75
|
1.10
|
1.74
|
1.54
|
1.59
|
|
|
|
|
|
|
Interest Coverage
|
40.90
|
57.17
|
108.10
|
183.95
|
213.86
|
88.41
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
8.79
|
9.39
|
10.77
|
11.82
|
10.72
|
10.66
|
|
|
|
|
|
|
Asset Turnover
|
1.39
|
1.08
|
1.11
|
1.08
|
0.95
|
0.87
|
|
|
|
|
|
|
Receivable days
|
--
|
31.88
|
35.81
|
36.53
|
35.03
|
38.57
|
|
|
|
|
|
|
Inventory Days
|
--
|
126.03
|
82.25
|
58.60
|
59.85
|
67.64
|
|
|
|
|
|
|
Payable days
|
--
|
163.79
|
124.39
|
131.27
|
214.92
|
220.48
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-5.88
|
-6.33
|
-36.14
|
-120.04
|
-114.26
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
